Isifo sesibindi esinamafutha sikhona kwi-spectrum ukusuka kwisibindi esilula samafutha (NAFLD) ukuya kwisibindi esinamafutha avuthayo (NASH).EUnited States, ukuxhaphaka kwezifo zesibindi ezinamafutha ukusuka kwi-10-46% yeepesenti, kunye nezifundo ezisekelwe kwi-biopsy yesibindi zibika ukuxhaphaka kwe-NASH ye-1-17%.Uphononongo olucwangcisiweyo lubonisa ukuxhaphaka kwe-NAFLD kubantu abadala mhlawumbi i-25-33%, ngelixa i-NASH ixhaphake yi-2-5%.Ngokuqhelekileyo, izigulana ezinezilonda eziphambili ze-NASH zisemngciphekweni wokuphuhlisa izicubu ezibomvu esibindini (fibrosis) ezinokuqhubela phambili kwi-cirrhosis kunye nesifo sesibindi sokugqibela.Ke ngoko, ukujonga ukusebenza kwesibindi kuye kwaba yinxalenye ebalulekileyo yobomi bemihla ngemihla.
I-Konsung ephathekayo ye-biochemical analyzer ephathwayo isebenzisa indlela yokubona ukukhanya, eqinisekisa ukuchaneka komgangatho wekliniki (CV≤5%).Ifuna kuphela i-45μL yegazi leminwe, ixabiso le-ALB, i-ALT kunye ne-AST iya kuvavanywa ngaphakathi kwe-3 min kwaye iziphumo zovavanyo zibonisa kwi-4.3 touch screen.Ukugcinwa kweziphumo zovavanyo ezingama-3000 kubonelela ngokulula kakhulu kokubeka iliso ukusebenza kwesibindi kubomi bemihla ngemihla.
Konsung zonyango, gxila kwiinkcukacha ezingaphezulu zakho#ukhathalelo lwempilo.
Ixesha lokuposa: Mar-24-2022